Assenagon Asset Management
MED icon

Assenagon Asset Management’s Medifast MED Stock Holding History

Assenagon Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-64,461
Closed -$8.06M – 1038
2018
Q4 		$8.06M Buy
+64,461
New +$11M 0.09% 176
2018
Q1 		– Sell
-34,616
Closed -$2.42M – 667
2017
Q4 		$2.42M Buy
+34,616
New +$2.3M 0.02% 421

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Assenagon Asset Management's MED Position: Q1 2019 in Review

Assenagon Asset Management sold out of Medifast (MED) in Q1 2019, closing a stake of 64,461 shares — an estimated $8.06M sold.

Assenagon Asset Management first reported a position in MED in Q4 2017 and held it in 2 quarters. The position peaked at $8.06M in Q4 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • Assenagon Asset Management reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 64,461 Medifast shares in Q1 2019, an estimated $8.06M.
  • Assenagon Asset Management first reported a position in Medifast in Q4 2017 and held it in 2 quarters.
  • Assenagon Asset Management's Medifast position peaked at $8.06M in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Assenagon Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.